TRT Dose Titration: How To Adjust Testosterone Safely

TRT dose titration is the process of adjusting a testosterone replacement therapy dose in small, lab-guided increments until symptoms improve and blood markers fall within a safe range. It's a cycle of bloodwork, dose changes, and waiting periods that most men repeat two to three times before reaching a stable protocol.

The most common mistake isn't picking the wrong starting dose. It's changing that dose too soon or without the right lab data. Testosterone cypionate takes roughly five to six half-lives (about 5-6 weeks) to reach steady state (Bhasin et al., 2018). Premature lab draws are a frequent driver of unnecessary dose escalation.

Marek Health builds every testosterone replacement protocol around lab-confirmed adjustments, not symptom guessing.

What Does TRT Dose Titration Mean?

TRT dose titration is the clinical practice of raising or lowering a testosterone dose based on measured serum levels and symptom response. The Endocrine Society's 2018 guideline recommends titrating testosterone to a mid-normal serum concentration (Bhasin et al., 2018). The AUA guideline targets the middle tertile of the normal reference range (Mulhall et al., 2018).

Individual pharmacokinetics vary widely. Two men on the same weekly dose can produce trough levels that differ by several hundred ng/dL, depending on SHBG, body composition, and metabolic clearance rate.

Where Do Most Providers Start the Dose?

Most TRT protocols begin at 100 mg of testosterone cypionate or enanthate per week. The prescribing information for Depo-Testosterone lists a range of 50-400 mg every 2-4 weeks, adjusted by clinical response (FDA Label, 2018). Splitting into two injections per week is now common because smaller, more frequent doses may reduce peak-to-trough swings and estradiol fluctuations.

SHBG levels influence how much testosterone is biologically available. The prescribing provider determines the starting point based on the individual's full lab panel and clinical picture.

How Long Before Labs Should Be Drawn?

The first titration labs should not be drawn sooner than six weeks after starting or changing a dose. Steady state requires approximately five half-lives. Drawing blood at week three or four captures a system still stabilizing and commonly returns trough values that look lower than they will at true steady state.

Labs should be drawn at trough, meaning the morning of the next scheduled injection, before injecting. Drawing at different points in the injection cycle can produce meaningfully different results.

What Labs Guide the Titration Decision?

A titration panel is not just total testosterone. Several markers need to move in the right direction at the same time.

A patient's provider determines the appropriate ranges based on symptoms, history, and clinical picture.

The Endocrine Society recommends checking hematocrit at 3-6 months, then annually (Bhasin et al., 2018). When symptoms persist despite adequate total testosterone, providers should check free testosterone, SHBG, thyroid function, and ferritin before raising the dose.

How Should the Dose Be Adjusted?

Each adjustment typically changes the weekly dose by a small increment, followed by a 6-8 week wait before rechecking labs.

Titration generally follows this pattern, though specifics depend on each patient's labs, symptoms, and medical history:

1. The provider selects a starting dose, often split into two injections per week.

2. Trough labs are drawn at week 6-8.

3. Based on levels and symptoms, the provider may increase, hold, or reduce the dose.

4. Labs are repeated 6-8 weeks after any change.

5. Once stable, monitoring moves to quarterly and then annually.

All dose decisions should be made in consultation with the prescribing provider based on the individual's full clinical picture. Most men reach a stable dose within two to three adjustment cycles.

Does Injection Frequency Affect Titration?

Frequency changes are often a better first move than dose increases. Splitting the same weekly total into smaller, more frequent injections flattens the testosterone curve.

Subcutaneous injection of testosterone cypionate and enanthate is considered off-label. Providers should discuss route selection as part of shared decision-making.

Men who experience mid-week fatigue or mood dips on a once-weekly protocol often improve by splitting to twice weekly without changing the total dose. This is a frequency titration, not a dose titration.

What Are the Risks of Titrating Too High?

Pushing testosterone above the physiologic range doesn't add proportional benefit. It adds risk. The February 2025 FDA labeling update added a blood pressure warning based on TRAVERSE trial data (FDA, 2025; Lincoff et al., 2023).

TRAVERSE enrolled 5,246 men aged 45-80 with hypogonadism and cardiovascular risk factors. The primary cardiac endpoint (MACE) showed no significant difference (7.0% vs. 7.3%), but the testosterone group had higher rates of atrial fibrillation, acute kidney injury, and pulmonary embolism (Lincoff et al., 2023). TRAVERSE is not a blanket safety endorsement.

The Endocrine Society recommends holding testosterone if hematocrit exceeds 54% (Bhasin et al., 2018). Other risks include acne, fluid retention, mood instability, and elevated estradiol from excess aromatization.

What Signs Suggest the Dose Needs Adjustment?

Not all dose problems show up in labs first. The following symptoms may be associated with dosing, but each has multiple potential causes. A provider should evaluate the full clinical picture before attributing them to testosterone levels.

Symptoms that may suggest underdosing (other causes should be ruled out first): Persistent fatigue. Low libido. Difficulty maintaining muscle mass. Poor concentration.

Symptoms that may suggest excess dosing: Acne. Water retention. Elevated blood pressure. Mood swings. Sleep disturbances or worsening sleep apnea.

These symptom clusters overlap, which is why labs are not optional. A man who reports persistent low testosterone symptoms may assume the dose is too low when elevated estradiol from excess aromatization is the actual issue. A dose increase could worsen the problem.

How Does TRT Dose Titration Fit Into Long-Term Monitoring?

Once a stable dose is reached, monitoring doesn't stop. The Endocrine Society recommends periodic evaluation of symptoms, serum testosterone, and hematocrit (Bhasin et al., 2018). The AUA guideline confirms that testosterone deficiency requires ongoing management (Mulhall et al., 2018).

Fertility is a separate consideration. Testosterone suppresses sperm production in most men. Recovery after discontinuation is possible but uncertain and not assured. Men interested in maintaining fertility on TRT should raise this concern with a provider before starting therapy.

Testosterone is a Schedule III controlled substance requiring clinical evaluation and lab confirmation. Marek Health provides telehealth evaluations for men with suspected testosterone deficiency, with licensed providers directing every TRT dose titration decision through ongoing collaboration guided by labs, symptoms, and clinical judgment.

Disclaimer: This blog post is intended for informational purposes only and should not be considered medical advice. Always consult a healthcare professional before making changes to your health routine.

FAQs

How often should testosterone levels be checked during TRT dose titration?

Labs should be drawn 6-8 weeks after starting therapy or after any dose change, at trough (the morning of the next scheduled injection, before injecting). The Endocrine Society 2018 guideline recommends monitoring testosterone, hematocrit, and symptoms at 3-6 months, then annually once the dose is stable. Consistent timing matters because drawing labs at different points in the injection cycle can produce meaningfully different results.

What is a normal trough testosterone level on TRT?

The Endocrine Society recommends titrating to a mid-normal serum concentration. The AUA guideline targets the middle tertile of the normal reference range. The right level varies by individual. Symptom response matters alongside the number, and a patient's provider determines the appropriate therapeutic window.

How much should a TRT dose be adjusted at a time?

Adjustments are typically small increments in one direction, followed by a 6-8 week stabilization period before rechecking labs. Larger jumps increase the risk of side effects disproportionately. The prescribing provider determines the specific increment based on the patient's labs and clinical response.

Can injection frequency affect TRT dose titration results?

Splitting the same weekly total into more frequent, smaller doses may flatten the serum testosterone curve. Twice-weekly injections tend to produce more stable levels than once-weekly injections at the same total dose. Men who experience mid-week fatigue or mood dips on a weekly protocol may improve by splitting to twice weekly without changing the total amount.

What happens if hematocrit gets too high on TRT?

The Endocrine Society recommends holding testosterone therapy if hematocrit rises above the guideline threshold and not restarting until it drops to a safe level. In the TRAVERSE trial, a small but meaningful percentage of testosterone-treated men reached elevated hematocrit levels compared with placebo. Dose reduction, increased injection frequency, or therapeutic phlebotomy are common interventions. The provider determines the appropriate response.

Is TRT dose titration different for men with high SHBG?

Men with higher SHBG bind more testosterone in the blood, leaving less bioavailable. They may need different starting doses and should have free testosterone measured alongside total testosterone at each titration visit. Adjusting based on total testosterone alone can leave high-SHBG men undertreated. The prescribing provider accounts for SHBG when making dose decisions.

How long does it take to find a stable TRT dose?

Most men reach a stable dose within two to three adjustment cycles, which typically takes several months from the start of therapy. Each cycle involves a stabilization period followed by labs and a potential small adjustment. Changing only one variable per cycle (dose or frequency, not both) is the approach that produces the most reliable results.

References

• J Clin Endocrinol Metab. 2018;103(5):1715-1744

• Depo-Testosterone Prescribing Information. Pharmacia & Upjohn. Revised 2018

• FDA Drug Alert: Class-Wide Labeling Changes for Testosterone Products. February 2025

• N Engl J Med. 2023;389:107-117

• J Urol. 2018. AUA Testosterone Deficiency Guideline